BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16395830)

  • 21. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Fever in neutropenic patients with cancer.
    Barber FD
    Nurs Clin North Am; 2001 Dec; 36(4):631-44, v. PubMed ID: 11726344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
    Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic prophylaxis in neutropenic children with acute leukemia: Do the presently available data really support this practice?
    Calitri C; Ruberto E; Castagnola E
    Eur J Haematol; 2018 Dec; 101(6):721-727. PubMed ID: 30107054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
    te Poele EM; Tissing WJ; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empiric therapy for febrile neutropenia: what are the choices?
    Aoun M
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):507-15. PubMed ID: 17547514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current considerations in the management of fever and neutropenia.
    Alexander SW; Pizzo PA
    Curr Clin Top Infect Dis; 1999; 19():160-80. PubMed ID: 10472485
    [No Abstract]   [Full Text] [Related]  

  • 28. There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy.
    Bow EJ
    J Antimicrob Chemother; 2013 Mar; 68(3):492-5. PubMed ID: 23299574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacterial infections in neutropenic patients with cancer].
    Matysiak M
    Przegl Lek; 2003; 60 Suppl 5():54-7. PubMed ID: 14575008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic approach to a patient with febrile neutropenia].
    Duraković N; Nemet D
    Lijec Vjesn; 2007; 129(10-11):344-50. PubMed ID: 18257335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
    Durnaá B; Dzierzanowska D
    Wiad Lek; 2006; 59(7-8):506-11. PubMed ID: 17209349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia.
    Wingard JR; Eldjerou L; Leather H
    Curr Opin Hematol; 2012 Jan; 19(1):21-6. PubMed ID: 22080847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
    Pizzo PA
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i16-7. PubMed ID: 19372174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
    Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
    [No Abstract]   [Full Text] [Related]  

  • 36. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
    Bodey GP
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i3-13. PubMed ID: 19372179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacterial infections in pediatric cancer patients].
    Simon A; Beutel K; Marklein G; Fleischhack G
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S17-36. PubMed ID: 16288351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious complications in neutropenic cancer patients.
    Menichetti F
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S21-5. PubMed ID: 20865470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutropenia: clinical implications and modulation.
    Glauser MP
    Intensive Care Med; 2000; 26 Suppl 1():S103-10. PubMed ID: 10786966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.